AstraZeneca says it is withdrawing Vaxzevria, its vaccine to protect against COVID-19, from global markets. The vaccine was used early on in the pandemic in many countries, including Canada. In an …
This story is part of CBC Health’s Second Opinion, a weekly analysis of health and medical science news emailed to subscribers on Saturday mornings. If you haven’t subscribed yet, you can …
People 65 years of age and older may receive another dose of updated vaccine to protect against severe illness from COVID-19, Canada’s advisory body on immunizations said Friday. The National …
Health Canada has approved a new vaccine geared toward protecting two groups most severely affected by the respiratory syncytial virus (RSV): newborns, who would receive antibodies through maternal immunization, and Canadians …
Only about 14 per cent of eligible New Brunswickers have received the new COVID-19 vaccine designed to target the Omicron XBB.1.5 subvariant, figures from the Department of Health show. Meanwhile, more than a third …
The Dose24:13What are the best ways to treat a cold? Featured VideoOral cold and cough medicine containing a popular decongestant was pulled from some U.S. pharmacy shelves this week. This …